Bladder Disease

1. Front Matter

   Pages i-xxvi

   PDF

2. Oncology and Cellular Biology

   1. Front Matter

      Pages 1-1

      PDF

   2. Recent Developments in the Treatment of Bladder Cancer

      • Raymond S. Lance, H. Barton Grossman

      Pages 3-14

   3. Interferon-α Response and Signal Transduction Pathway in Transitional Carcinoma Cell Lines

      • Sudip K. Bandyopadhyay, Raymond R. Rackley, Surena F. Matin, Provash C. Sadhukhan

      Pages 15-32

   4. Molecular Cloning and Expression of Uroplakins in Transitional Cell Carcinoma

      • Takeshi Yuasa, Tatsuhiro Yoshiki, Takahiro Isono, Tsutomu Tanaka, Yusaku Okada

      Pages 33-46

   5. Application of a Novel Protein Chip Mass Spectrometry Technology for the Identification of Bladder Cancer-Associated Biomarkers

      • Antonia Vlahou, Paul F. Schellhammer, George L. Wright Jr.

      Pages 47-60

   6. The Photodynamic Diagnosis (PDD) for Early Detection of Carcinoma and Dysplasia of the Bladder

      • A. Zumbraegel, K.-H. Bichler, F. S. Krause, G. Feil, H. J. Nelde

      Pages 61-66

   7. Prediction of Lymph Node Metastasis Based on P53 and NM23-H1 Expression in Muscle Invasive Grade III Transitional Cell Carcinoma of Bladder

      • Dong Soo Park, Young Tae Lee, Jin Moo Lee

      Pages 67-85

   8. Detection of Her-2/Neu Cep 17 Mutations at Invasive Bladder Cancer

      • Gerhard Feil, F. Steffen Krause, Andreas Zumbraegel, Karl-H. Bichler

      Pages 87-97

   9. KI67, P53, NM23, and DNA Cytometry IN Bladder Cancer: Potential Markers for Detection of Recurrence?

      • Gerhard Feil, F. Steffen Krause, Andreas Zumbraegel, Hans W. Wechsel, Karl-H. Bichler

      Pages 99-109

   10. Comparison of Cytology and Nuclear Matrix Protein 22 (NMP 22) for the Detection and Follow-Up of Bladder-Cancer

       • Sven Lahme, Karl-Horst Bichler, Gerhard Feil, Andreas Zumbrägel, Tobias Götz

       Pages 111-119

   11. The Effect of Contrast Material on Transitional Cell Carcinoma Viability

       • Martha K. Terris

       Pages 121-128

   12. Fluorodeoxyglucose Positron Emission Tomography Studies in the Diagnosis and Staging of Transitional Cell Carcinoma

       • I. Jenna Liu, George M. Segall, Matilde Nino-Murcia, Martha K. Terris

       Pages 129-142

   13. Radiochemotherapy in Locally Invasive Non-Metastatic Carcinoma of the Bladder

       • J. L. Brod, R. Kühn, W. Schafhauser, K. M. Schrott

       Pages 143-153

   14. Gene and Antisense Therapy of Bladder Cancer

       • Peter Ardelt, Ingo Kausch, Andreas Böhle

       Pages 155-183

   15. Tumor Suppressor Genes of Bladder Cancer and Potential for Gene Therapy

       • Motoyoshi Tanaka, H. Barton Grossman

       Pages 185-191

3. Muscle, Matrix and Obstruction

   1. Front Matter

      Pages 193-193

      PDF

   2. Molecular Response of the Bladder to Obstruction

      • Andrew J. Kirsch, Edward J. Macarak, Brahim Chaqour, Theresa Quinn, Stephen Zderic, Alan Flake et al.

      Pages 195-216

   3. The Role of Lipids and Lipid Metabolites in Urinary Bladder Dysfunction Induced by Partial Outlet Obstruction

      • Martha A. Hass, Robert M. Levin

      Pages 217-237

   4. Intercellular Communication and Bladder Function

      • George J. Christ, Karicheti Venkateswarlu, Nancy S. Day, Mira Valcic, Cristian Santizo, Weixin Zhao et al.

      Pages 239-254

In 1996, the National Bladder Foundation (NBF) was founded by a dedicated group of physicians and researchers propeIled by the urgent need to find better treatments for bladder disease. Committed to increasing bladder disease research and to supporting its research community, the NBF coordinates and sponsors the International Bladder Symposium (IBS) in Washington, DC. Now considered to be a premier scientific assembly, the IBS brings together international leaders in bladder disease research to present and discuss their findings. It is the only international conference where all areas of bladder disease research are exclusively covered and where bladder disease researchers are provided with a unique opportunity to share their results and theories. IBS participants contributed the research papers included in this publication in 2000 and 2001. AIl substantial areas of bladder disease research are addressed, including oncology and ceIlular biology, neurophysiology, neurogenic bladder andincontinence, immunology, inflammation and infection, muscle, matrix and obstruction, and new frontiers and therapies of the bladder. Assembled in one publication, these papers and their findings demonstrate the high scientific caliber of the dedicated researchers in this field and the potential for significant discoveries in treatment options in the next decade.

• Staging
• angiogenesis
• apoptosis
• cancer
• carcinoma
• chemotherapy
• gene therapy
• infection
• infections
• inflammation
• interferon
• oncology
• pathogenesis
• physiology
• surgery

• Children’s Hospital and Harvard Medical School, Boston, USA

  Anthony Atala

• Ridgefield, USA

  Debra Slade

Policies and ethics